Shan, Khine S. and Bonano-Rios, Amalia and Theik, Nyein Wint Yee and Hussein, Atif and Blaya, Marcelo (2024) Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers. International Journal of Molecular Sciences, 25 (4). p. 1973. ISSN 1422-0067
ijms-25-01973.pdf - Published Version
Download (3MB)
Abstract
The dysregulation of the phosphatidylinositol-3-kinase (PI3K) pathway can lead to uncontrolled cellular growth and tumorigenesis. Targeting PI3K and its downstream substrates has been shown to be effective in preclinical studies and phase III trials with the approval of several PI3K pathway inhibitors by the Food and Drug Administration (FDA) over the past decade. However, the limited clinical efficacy of these inhibitors, intolerable toxicities, and acquired resistances limit the clinical application of PI3K inhibitors. This review discusses the PI3K signaling pathway, alterations in the PI3K pathway causing carcinogenesis, current and novel PI3K pathway inhibitors, adverse effects, resistance mechanisms, challenging issues, and future directions of PI3K pathway inhibitors.
Item Type: | Article |
---|---|
Subjects: | Article Paper Librarian > Multidisciplinary |
Depositing User: | Unnamed user with email support@article.paperlibrarian.com |
Date Deposited: | 07 Feb 2024 06:35 |
Last Modified: | 07 Feb 2024 06:35 |
URI: | http://editor.journal7sub.com/id/eprint/2633 |